Randomised Trial of a Yogurt-Type Amino Acid-Based Formula in Infants and Children With Severe Cow's Milk Allergy.

Objectives: Evaluation of a spoon-fed amino acid-based formula (AAF) with a yogurt-type texture compared to the reference oral liquid formula (Neocate(R)). Methods: Phase III/IV, prospective, randomized (1:1), open-label, multicenter study in infants/young children (6-36 months) with severe cow's milk protein allergy (CMA) who had consumed AAF for >=1 month before the study. Patients received reference+test formula (Neocate(R) with a yogurt-type texture for spoon-feeding: Group 1) or reference formula (Group 2) for 28 days. The study formulae were integrated into the patients' usual daily diet. Efficacy on Day 0, 14, and 28 was assessed primarily in terms of symptoms associated with CMA. The evolution of symptoms, amount of formula consumed, nutritional and energy intake, anthropometric data, and tolerability were also assessed. Results: The incidence of CMA symptoms was similar in each group (p > 0.05) on Day 0, 14, and 28. For specific symptoms, there was little change from Day 0 and no significant difference between groups for incidence on Day 0 or evolution at Day 14 or 28. There was no difference in formula consumption (Day 0-28) between groups (p = 0.90), but nutritional value was generally higher for Group 1 and calcium intake was statistically higher for Group 1 (p

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2A7xzYk
via IFTTT